Your browser doesn't support javascript.
The safety of SARS-CoV-2 vaccines in persons with a known history of pegaspargase allergy: A single institution experience.
Rush, Cassandra; Faulk, Kelly E; Bradley, Zanette Kanani; Turner, Aubree; Krumins, Maija; Greenhawt, Matthew.
  • Rush C; Pharmacy Department, Children's Hospital Colorado, Aurora, Colo.
  • Faulk KE; Center for Cancer and Blood Disorders, Children's Hospital Colorado, Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colo.
  • Bradley ZK; Pharmacy Department, Children's Hospital Colorado, Aurora, Colo.
  • Turner A; Pharmacy Department, Children's Hospital Colorado, Aurora, Colo.
  • Krumins M; Pharmacy Department, Children's Hospital Colorado, Aurora, Colo.
  • Greenhawt M; Section of Allergy and Immunology, Children's Hospital Colorado, Department of Pediatrics, University of Colorado School of Medicine, Aurora, Colo. Electronic address: Matthew.Greenhawt@childrenscolorado.org.
J Allergy Clin Immunol Pract ; 10(2): 630-632, 2022 02.
Article in English | MEDLINE | ID: covidwho-1559812

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Hypersensitivity Type of study: Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: J Allergy Clin Immunol Pract Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Hypersensitivity Type of study: Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: J Allergy Clin Immunol Pract Year: 2022 Document Type: Article